The LiquidBiopsy rare cell enrichment platform enables the industry’s only commercially available sample-to-genomic data workflow for analyzing circulating tumor cells and cell-free DNA from a single blood draw.

Unique Comprehensive Workflow

LiquidBiopsy automates the molecular characterization of ctcDNA, cfDNA, and germline DNA from a single sample of whole blood.

Patented Core Technology

Delivering both the high target cell
recovery and exceptional purity to support downstream analysis, LiquidBiopsy automates the isolation of tumor cells
from blood samples.

Technical Resources

Download product information, training materials and publications, and learn how the LiquidBiopsy workflow is used in peripheral monitoring applications.